Form 4 for CGEM Cullinan Therapeutics, Inc.
Accepted 2024-06-11 00:00:00 ET · period of report 2024-06-10 · accession 0000950170-24-072095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-11 | 2024-06-10 | CGEM | Ebeling Thomas | Dir | M - OptEx | $13.00 | +18.4K | 186.7K | +11% | +$239.8K |
| D | 2024-06-11 | 2024-06-10 | CGEM | Ebeling Thomas | Dir | M - OptEx | $0.00 | -18.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-10 | M | A | 18,450 | $13.00 | 186,653 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-10 | M | D | 18,450 | $0.00 | 0 | D | $13.00 · 2024-06-08 to 2033-06-07 | 18,450 Common Stock |